Find Exarafenib manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Kin-2787 free base, 2vpx8hl8ab, Exarafenib [inn], Unii-2vpx8hl8ab, Schembl23275448, Gtpl12095
Molecular Formula
C26H34F3N5O3
Molecular Weight
521.6  g/mol
InChI Key
GZMYLSJUNSCMTD-MOPGFXCFSA-N
FDA UNII
2VPX8HL8AB

Exarafenib
1 2D Structure

Exarafenib

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(3S)-N-[3-[2-[[(2R)-1-hydroxypropan-2-yl]amino]-6-morpholin-4-ylpyridin-4-yl]-4-methylphenyl]-3-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide
2.1.2 InChI
InChI=1S/C26H34F3N5O3/c1-17-3-4-21(31-25(36)34-6-5-19(15-34)14-26(27,28)29)13-22(17)20-11-23(30-18(2)16-35)32-24(12-20)33-7-9-37-10-8-33/h3-4,11-13,18-19,35H,5-10,14-16H2,1-2H3,(H,30,32)(H,31,36)/t18-,19+/m1/s1
2.1.3 InChI Key
GZMYLSJUNSCMTD-MOPGFXCFSA-N
2.1.4 Canonical SMILES
CC1=C(C=C(C=C1)NC(=O)N2CCC(C2)CC(F)(F)F)C3=CC(=NC(=C3)N4CCOCC4)NC(C)CO
2.1.5 Isomeric SMILES
CC1=C(C=C(C=C1)NC(=O)N2CC[C@H](C2)CC(F)(F)F)C3=CC(=NC(=C3)N4CCOCC4)N[C@H](C)CO
2.2 Other Identifiers
2.2.1 UNII
2VPX8HL8AB
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Kin-2787 Free Base

2. 2vpx8hl8ab

3. Exarafenib [inn]

4. Unii-2vpx8hl8ab

5. Schembl23275448

6. Gtpl12095

7. Bdbm514652

8. Us11098031, Example 14

9. Example 14 [wo2021081375a1]

10. Hy-147268

11. Cs-0542473

12. (3s)-n-(3-(2-(((2r)-1-hydroxypropan-2-yl)amino)-6- (morpholin-4-yl)pyridin-4-yl)-4-methylphenyl)-3-(2,2,2- Trifluoroethyl)pyrrolidine-1-carboxamide

13. (3s)-n-[3-[2-[[(2r)-1-hydroxypropan-2-yl]amino]-6-morpholin-4-ylpyridin-4-yl]-4-methylphenyl]-3-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide

14. (s)-n-(3-(2-(((r)-1-hydroxypropan-2- Yl)amino)-6-morpholinopyridin-4-yl)-4- Methylphenyl)-3-(2,2,2- Trifluoroethyl)pyrrolidine-1-carboxamide

15. 1-pyrrolidinecarboxamide, N-(3-(2-(((1r)-2-hydroxy-1-methylethyl)amino)-6-(4-morpholinyl)-4-pyridinyl)-4-methylphenyl)-3-(2,2,2-trifluoroethyl)-, (3s)-

16. 2639957-39-2

2.4 Create Date
2021-08-21
3 Chemical and Physical Properties
Molecular Weight 521.6 g/mol
Molecular Formula C26H34F3N5O3
XLogP34
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count9
Rotatable Bond Count7
Exact Mass521.26137445 g/mol
Monoisotopic Mass521.26137445 g/mol
Topological Polar Surface Area90 Ų
Heavy Atom Count37
Formal Charge0
Complexity739
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty